ICU Medical, Incorporated (ICUI) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its position in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 13.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,988 shares of the medical instruments supplier’s stock after selling 3,459 shares during the period. California Public Employees Retirement System’s holdings in ICU Medical were worth $6,750,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Millennium Management LLC boosted its position in shares of ICU Medical by 5.9% during the first quarter. Millennium Management LLC now owns 548,769 shares of the medical instruments supplier’s stock worth $138,509,000 after buying an additional 30,676 shares during the period. Renaissance Technologies LLC boosted its holdings in ICU Medical by 1.1% in the second quarter. Renaissance Technologies LLC now owns 312,500 shares of the medical instruments supplier’s stock valued at $91,766,000 after purchasing an additional 3,400 shares during the period. OppenheimerFunds Inc. boosted its holdings in ICU Medical by 58.1% in the second quarter. OppenheimerFunds Inc. now owns 225,807 shares of the medical instruments supplier’s stock valued at $66,308,000 after purchasing an additional 82,976 shares during the period. FMR LLC boosted its holdings in ICU Medical by 1.4% in the second quarter. FMR LLC now owns 116,630 shares of the medical instruments supplier’s stock valued at $34,249,000 after purchasing an additional 1,634 shares during the period. Finally, Federated Investors Inc. PA boosted its holdings in ICU Medical by 623.9% in the second quarter. Federated Investors Inc. PA now owns 86,204 shares of the medical instruments supplier’s stock valued at $25,314,000 after purchasing an additional 74,296 shares during the period. Institutional investors and hedge funds own 74.29% of the company’s stock.

In related news, VP Virginia Ruth Sanzone sold 787 shares of ICU Medical stock in a transaction on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the completion of the transaction, the vice president now directly owns 1,367 shares in the company, valued at $414,365.04. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Thomas D. Mccall sold 11,133 shares of ICU Medical stock in a transaction on Friday, August 24th. The shares were sold at an average price of $302.56, for a total value of $3,368,400.48. Following the completion of the transaction, the vice president now owns 3,018 shares of the company’s stock, valued at $913,126.08. The disclosure for this sale can be found here. Over the last quarter, insiders sold 711,920 shares of company stock valued at $202,651,956. 12.50% of the stock is currently owned by company insiders.

NASDAQ:ICUI opened at $265.80 on Friday. The firm has a market capitalization of $5.79 billion, a P/E ratio of 47.73 and a beta of 0.41. ICU Medical, Incorporated has a 12-month low of $180.45 and a 12-month high of $321.70.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.82 by $0.84. The firm had revenue of $360.46 million during the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. ICU Medical’s revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $0.76 earnings per share. As a group, research analysts anticipate that ICU Medical, Incorporated will post 7.6 EPS for the current year.

ICUI has been the subject of a number of recent research reports. TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th. ValuEngine lowered ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. BidaskClub lowered ICU Medical from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 20th. Finally, Zacks Investment Research upgraded ICU Medical from a “hold” rating to a “strong-buy” rating and set a $337.00 target price for the company in a report on Wednesday, August 15th. One research analyst has rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $337.00.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: Intrinsic Value

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply